|
HAUS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.341800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.556990E-01 |
| Normal-vs-Stage2 |
1.755240E-01 |
| Normal-vs-Stage3 |
6.199600E-01 |
| Normal-vs-Stage4 |
4.836000E-01 |
| Stage1-vs-Stage2 |
3.849200E-01 |
| Stage1-vs-Stage3 |
1.500840E-01 |
| Stage1-vs-Stage4 |
6.217600E-01 |
| Stage2-vs-Stage3 |
1.298350E-01 |
| Stage2-vs-Stage4 |
8.981800E-01 |
| Stage3-vs-Stage4 |
4.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.260400E-02 |
| Normal-vs-AfricanAmerican |
1.189250E-01 |
| Normal-vs-Asian |
1.294030E-01 |
| Caucasian-vs-AfricanAmerican |
8.872000E-01 |
| Caucasian-vs-Asian |
7.804000E-01 |
| AfricanAmerican-vs-Asian |
8.120400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.552300E-02 |
| Normal-vs-Female |
7.359600E-02 |
| Male-vs-Female |
9.165200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.905400E-01 |
| Normal-vs-Extreme_Weight |
5.569600E-01 |
| Normal-vs-Obese |
1.232420E-01 |
| Normal-vs-Extreme_Obese |
3.151600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.191400E-01 |
| Normal_Weight-vs-Obese |
7.595000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.047000E-01 |
| Extreme_Weight-vs-Obese |
2.833800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.466000E-01 |
| Obese-vs-Extreme_Obese |
9.008600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.030400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.798900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.867820E-01 |
| Normal-vs-Age(81-100Yrs) |
8.764200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.383800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.801600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.163800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.873220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.363300E-03 |
| Normal-VS-Type2 PRCC |
9.345200E-01 |
| Normal-VS-KIRP CIMP |
3.986000E-02 |
| Normal-VS-Unclassified PRCC |
8.363800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.606500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.140000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.928400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.042100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.006000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.184300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.620600E-01 |
| Normal-vs-N1 |
2.026000E-01 |
| Normal-vs-N2 |
8.222300E-02 |
| N0-vs-N1 |
2.013000E-01 |
| N0-vs-N2 |
2.428400E-01 |
| N1-vs-N2 |
2.734400E-02 |
|
|
